Yusuke Furukawa conducts interdisciplinary study in the fields of Cell biology and DNA through his research. He performs integrative DNA and Cell biology research in his work. He carries out multidisciplinary research, doing studies in Gene and Transcription factor. Many of his studies on Biochemistry involve topics that are commonly interrelated, such as Apoptosis. Many of his studies on Apoptosis apply to Biochemistry as well. In his work, he performs multidisciplinary research in Molecular biology and Cell culture. He performs integrative study on Cell culture and Molecular biology in his works. Cancer research and Genetics are two areas of study in which he engages in interdisciplinary work. In his work, he performs multidisciplinary research in Genetics and Cancer research.
Many of his research projects under Receptor are closely connected to Cell biology with Cell biology, tying the diverse disciplines of science together. His Apoptosis research extends to the thematically linked field of Biochemistry. Much of his study explores Cell biology relationship to Stem cell. In his articles, he combines various disciplines, including Stem cell and Haematopoiesis. His research on Gene expression and Cell cycle is centered around Gene. Yusuke Furukawa integrates Gene expression with Gene in his research. In his works, he conducts interdisciplinary research on Cancer research and Genetics. He performs multidisciplinary study in the fields of Genetics and Cancer research via his papers. Yusuke Furukawa merges Molecular biology with Cell culture in his study.
Yusuke Furukawa combines Internal medicine and Dermatology in his research. In his study, Yusuke Furukawa carries out multidisciplinary Immunology and Hematology research. He applies his multidisciplinary studies on Cancer research and Somatic evolution in cancer in his research. Borrowing concepts from Cancer research, he weaves in ideas under Somatic evolution in cancer. In his research, he performs multidisciplinary study on Multiple myeloma and Carfilzomib. Yusuke Furukawa integrates several fields in his works, including Carfilzomib and Proteasome inhibitor. Yusuke Furukawa undertakes multidisciplinary studies into Proteasome inhibitor and Cancer in his work. His work often combines Cancer and Multiple myeloma studies. He connects Gene with Evolutionary biology in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.
James A. DeCaprio;John W. Ludlow;Dennis Lynch;Yusuke Furukawa.
Signal transduction of the human granulocyte-macrophage colony- stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins
Yuzuru Kanakura;Brian Druker;Stephen A. Cannistra;Yusuke Furukawa.
In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents
Yasuhiko Kano;Miyuki Akutsu;Saburo Tsunoda;Hiroyuki Mano.
The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.
James A. Decaprio;Yusuke Furukawa;Florence Ajchenbaum;James D. Griffin.
Proceedings of the National Academy of Sciences of the United States of America (1992)
cdc2 gene expression at the G1 to S transition in human T lymphocytes
Yusuke Furukawa;Helen Piwnica-Worms;Timothy J. Ernst;Yuzuru Kanakura.
Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
K Noborio-Hatano;J Kikuchi;M Takatoku;R Shimizu.
A Janus Kinase Inhibitor, JAB, Is an Interferon-γ–Inducible Gene and Confers Resistance to Interferons
Hiroshi Sakamoto;Hideo Yasukawa;Masaaki Masuhara;Shyu Tanimura.
Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells
Y Furukawa;J A DeCaprio;A Freedman;Y Kanakura.
Proceedings of the National Academy of Sciences of the United States of America (1990)
Apaf-1 is a mediator of E2F-1-induced apoptosis.
Yusuke Furukawa;Noriko Nishimura;Yutaka Furukawa;Masaaki Satoh.
Journal of Biological Chemistry (2002)
Phosphorylation of Bcl-2 Protein by CDC2 Kinase during G2/M Phases and Its Role in Cell Cycle Regulation
Yusuke Furukawa;Satsuki Iwase;Jiro Kikuchi;Yasuhito Terui.
Journal of Biological Chemistry (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: